Rhodiola Rosea for Mental and Physical Fatigue
Λέξεις-κλειδιά
Αφηρημένη
Ημερομηνίες
| Τελευταία επαλήθευση: | 01/31/2011 |
| Πρώτα υποβλήθηκε: | 01/16/2011 |
| Υποβλήθηκε εκτιμώμενη εγγραφή: | 01/16/2011 |
| Δημοσιεύτηκε για πρώτη φορά: | 01/18/2011 |
| Υποβλήθηκε τελευταία ενημέρωση: | 02/13/2011 |
| Δημοσιεύτηκε η τελευταία ενημέρωση: | 02/14/2011 |
| Ημερομηνία έναρξης της πραγματικής μελέτης: | 12/31/2010 |
| Εκτιμώμενη κύρια ημερομηνία ολοκλήρωσης: | 03/31/2011 |
| Εκτιμώμενη ημερομηνία ολοκλήρωσης μελέτης: | 03/31/2011 |
Κατάσταση ή ασθένεια
Παρέμβαση / θεραπεία
Dietary Supplement: Rhodiola rosea
Φάση
Κριτήρια καταλληλότητας
| Επιλέξιμες ηλικίες για μελέτη | 19 Years Προς την 19 Years |
| Φύλα επιλέξιμα για μελέτη | All |
| Δέχεται υγιείς εθελοντές | Ναί |
| Κριτήρια | Inclusion Criteria: - Fourth year nursing students enrolled in NURS 495 (Nursing Practice) - Participating in permanent overnight (between 11 pm and 7 am) or rotating shift work - otherwise healthy - consent to participate in the study Exclusion Criteria: - nurses aged 18 years or younger - breastfeeding or pregnant women, as confirmed by a blood test - female participants with child bearing potential not practicing a form of birth control throughout the trial - presence of a primary medical condition associated with fatigue (e.g. cardiac, gastrointestinal, respiratory, renal, rheumatologic, or oncologic disease) - presence of schizophrenia, bipolar disorder, dementia, eating disorders, insomnia or substance abuse - presence of diabetes - concurrent utilization of hypoglycaemic or agents for raising or lowering blood pressure - known allergy or hypersensitivity to Rhodiola rosea or Sedum family extracts or pollen - know allergy to microcrystalline cellulose or silicone dioxide - concurrent utilization of stimulant drug such as methylphenidate (Ritalin), amphetamine (Dexedrine, Adderall), methamphetamine (Desoxyn) and pemoline (Cylert) - concurrent utilization of other rhodiola or ginseng products (both fall in the same therapeutic category known as an "adaptogen") - any significant medical condition - any neurological or mental health condition - taking medication that has central nervous system effects - aged 55 years or older - low blood pressure or history of significant dizziness |
Αποτέλεσμα
Πρωτεύοντα αποτελέσματα
1. Fatigue [42 days]
Δευτερεύοντα αποτελέσματα
1. Health-related quality of life [42 days]
2. Individualized Outcomes [42 days]
3. Adaptive Capacity [42 days]
4. Adverse Event Monitoring [42 days]
